Decision Diagnostics Corp.
DECN
Rank in Stocks
#34258
Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake... Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake Village, California, specializes in developing electronic medical record (EMR) technologies primarily optimized for smartphones. The company provides a wide array of offerings, including both regulated and unregulated diagnostic solutions, as well as home-use testing products for individuals managing chronic illnesses. They also facilitate direct-to-patient logistics for diabetes programs and concentrate on creating mobile-centric e-health products and associated technological innovations. A key part of their product line involves glucose monitoring. This includes the GenUltimate! glucose test strips, classified as a Class II medical device for personal at-home human use. For animal health, they manufacture PetSure! glucose test strips, designed to measure glucose levels in dogs and cats and compatible with legacy Zoetis AlphaTrak glucometers. Additionally, they offer the proprietary GenUltimate! 4Pets Glucose system, which combines the GenUltimate! 4Pets strip with the Avantage meter, enabling glucose testing for canine, feline, and equine patients. Further glucose strip options include GenUltimate! Sure and GenUltimate! Precis. Beyond product development, Decision Diagnostics actively acquires and maintains a portfolio of intellectual property, spanning patents, trademarks, and specialized manufacturing equipment. Their software solutions include MD@Hand, a comprehensive management system for both inpatient and outpatient care; Practice Probe, a data mining utility designed to extract information from physician practice management systems; and ResidenceWare, a residential management system that streamlines communication between commercial or residential real estate managers and their tenants through networked applications. Ultimately, their EMR innovations provide crucial tools for physicians directly at the point of patient care. The company was originally known as InstaCare Corp. before officially changing its name to Decision Diagnostics Corp. in November 2011.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$35.79K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Decision Diagnostics Corp. (DECN)
Category
Healthcare
EPS for Decision Diagnostics Corp. (DECN)
EPS as of September 2021 TTM: $-0.03
According to Decision Diagnostics Corp.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2020 the company had an EPS of $-0.11, a decrease compared to its 2019 EPS of $-0.02.
EPS history for Decision Diagnostics Corp. from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -75.45% |
| 2020 | $-0.11 | 428.85% |
| 2019 | $-0.02 | 16.20% |
| 2018 | $-0.02 | -43.53% |
| 2017 | $-0.03 | -29.08% |
| 2016 | $-0.04 | 0.00% |
| 2015 | $-0.04 | 5.42% |
| 2014 | $-0.04 | -88.22% |
| 2013 | $-0.36 | 28.57% |
| 2012 | $-0.28 | 7.69% |
| 2011 | $-0.26 | 268.27% |
| 2010 | $-0.07 | -118.58% |
| 2009 | $0.38 | 537.58% |
| 2008 | $0.06 | -105.23% |
| 2007 | $-1.14 | -73.73% |
| 2006 | $-4.34 | -59.74% |
| 2005 | $-10.78 | -52.09% |
| 2004 | $-22.50 | -3.97% |
| 2003 | $-23.43 | -67.13% |
| 2002 | $-71.27 | 27,311.54% |
| 2001 | $-0.26 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -6,359.26% |
US
|
|
| $1.93 | -7,251.11% |
SE
|
|
| $6.91 | -25,707.41% |
FR
|
|
| $0.02 | -172.22% |
HK
|
|
| $2.71 | -10,136.30% |
IT
|
Questions about Decision Diagnostics Corp.'s earnings per share (EPS)
What is Decision Diagnostics Corp.'s earnings per share (EPS)?
Decision Diagnostics Corp.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Sep 2021.
What was Decision Diagnostics Corp.'s earnings per share (EPS) in 2020?
In 2020, Decision Diagnostics Corp.'s earnings per share (EPS) was $-0.11, compared with $-0.02 in 2019.
How has Decision Diagnostics Corp.'s earnings per share (EPS) changed since 2015?
From 2015 to 2020, Decision Diagnostics Corp.'s earnings per share (EPS) was highest in 2019 ($-0.02) and lowest in 2020 ($-0.11).
How does Decision Diagnostics Corp.'s earnings per share (EPS) compare with similar companies?
Decision Diagnostics Corp.'s earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.